ICU MEDICAL INC/DE (ICUI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ICU MEDICAL INC/DE reported revenue of $2.23B, down 6.3% from the prior year. The company was profitable, with a net margin of 0.0% and a gross margin of 36.8%.
Key ratios (FY2025)
36.8%
Gross margin
1.9%
Operating margin
0.0%
Net margin
0.0%
Return on equity
-6.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379.37M |
| Cost of Revenue | $1.41B | $1.56B | $1.52B | $1.58B | $824.82M | $809.51M | $794.34M | $830.01M | $866.52M | $177.97M |
| Gross Profit | $822.04M | $824.78M | $739.87M | $697.76M | $491.49M | $461.50M | $471.86M | $570.03M | $426.10M | $201.40M |
| Operating Income | $42.83M | $42.96M | $22.82M | -$42.90M | $123.25M | $98.16M | $107.36M | $29.76M | -$13.29M | $82.94M |
| Net Income | $732.0K | -$117.69M | -$29.66M | -$74.29M | $103.14M | $86.87M | $101.03M | $28.79M | $68.64M | $63.08M |
| EPS (Diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 |
| Total Assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $704.69M |
| Shareholders' Equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B | $1.50B | $1.38B | $1.26B | $1.20B | $660.15M |
| Cash & Equivalents | — | — | — | $208.78M | $552.83M | $396.10M | $268.67M | $344.78M | $290.07M | $445.08M |
| Operating Cash Flow | $179.85M | $204.03M | $166.20M | -$62.13M | $267.54M | $222.75M | $101.92M | $160.22M | $154.42M | $89.94M |
| Capital Expenditures | $88.04M | $79.37M | $83.89M | $90.31M | $68.54M | $92.00M | $97.31M | $92.72M | $74.48M | $23.36M |
| Shares Outstanding | 24.90M | 24.39M | 24.09M | 23.87M | 21.78M | 21.59M | 21.55M | 21.60M | 20.86M | 17.25M |